Introduction:

While new therapies have increased survival for Hodgkin lymphoma (HL) in developed nations, the developing world still carries with most of the burden of this disease. Nevertheless, surveillance mechanisms for HL are lacking in Mexico.

Methods:

We developed a proxy for the burden of HL in Mexico using administrative data considering its prevalence, incidence, hospitalizations and mortality. The population consisted in individuals with International classification of diseases-10 code C81 attended in all Mexican institutions during 2016. The denominator of the rates was the age-specific population from census data. Structured interviews about treatment of HL were conducted with clinicians.

Results:

During 2016, 2,278 cases of HL were diagnosed; 3,241 patients were hospitalized and 535 died. The incidence rates of HL were 32% higher in males versus females. Adults aged 60 years or older had the highest incidence rates of HL, followed by adults between 20 and 24 years old. The strategies to treat HL were different between physicians working for the public and the private sector.

Conclusion:

The epidemiologic picture of HL in Mexico exhibits a pattern similar to that of developed countries. Our surrogate for the burden of HL will serve to plan and monitor future national cancer strategies.

        · resumen en Español     · texto en Español     · Español ( pdf )